Antimicrobial resistance in Vibrio cholerae O1/O139 clinical isolates: a systematic review and meta-analysis

References

• Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832.
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Mutreja A, Weill FX, et al. Corrigendum: revisiting the global epidemiology of cholera in conjunction with the genomics of Vibrio cholerae. Front Public Health. 2019;7:237.
   PubMed Web of Science ®Google Scholar
• Verma J, Bag S, Saha B, et al. Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae. Proc Natl Acad Sci U S A. 2019 Mar 26 116(13):6226–6231.
   PubMed Web of Science ®Google Scholar
• Chowdhury FR, Nur Z, and Hassan N, et al. Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming Ann Clin Microbiol Antimicrob. 2017;16(1):1–6.
   PubMedGoogle Scholar
• DJTJoid L. Global cholera epidemiology: opportunities to reduce the burden of cholera by 2030. J Infect Dis. 2018;218(suppl_3):S137–S140.
   PubMedGoogle Scholar
• Dalsgaard A, Serichantalergs O, Forslund A, et al. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. J Clin Microbiol. 2001;39(11):4086–4092.
   PubMed Web of Science ®Google Scholar
• Singh D, Matte MH, Matte G, et al. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Appl Environ Microbiol. 2001;67(2):910–921.
   PubMed Web of Science ®Google Scholar
• Awuor SO, Omwenga EO, Daud II, et al. Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio choisolateolates from Kisumu County, Kenya. Afr J Prim Health Care Fam Med. 2020;12(1). DOI:10.4102/phcfm.v12i1.2264
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Mutreja A, Weill F-X, et al. Revisiting the global epidemiology of cholera in conjunction with the genomics of Vibrio cholerae. Front Public Health. 2019;7:203.
   PubMed Web of Science ®Google Scholar
• Verma J, Bag S, Saha B, et al. Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae. Proceedings of the National Academy of Sciences. 2019;116(13):6226–6231.
   PubMed Web of Science ®Google Scholar
• Davies HG, Bowman C, Luby Spjjo I. Cholera–management and prevention. 2017;74:S66–S73.
   Google Scholar
• Pietroni MJV. Case management of cholera. 2020;38:A105–A109.
   Google Scholar
• Das B, Verma J, Kumar P, et al. Antibiotic resistance in Vibrio cholerae: understanding the ecology of resistance genes and mechanisms. Vaccine. 2020;38:A83–A92.
   PubMed Web of Science ®Google Scholar
• Mala W, Faksri K, Samerpitak K, et al. Antimicrobial resistance and genetic diversity of the SXT element in Vibrio cholerae from clinical and environmental water samples in northeastern Thailand. Infect Genet Evol. 2017; 52: 89–95.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Abana D, Gyamfi E, Dogbe M, et al. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana. BMC Infect Dis. 2019;19(1):1–10.
   PubMedGoogle Scholar
• Abera B, Bezabih B, Dessie A. Antimicrobial susceptibility of V. cholerae in the north west, Ethiopia. Ethiop Med J. 2010;48(1):23–28.
   PubMedGoogle Scholar
• Adabi M, Bakhshi B, Goudarzi H, et al. Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran. Microbial Drug Resist. 2009;15(3):179–184.
   PubMed Web of Science ®Google Scholar
• Ahmed D, Hoque A, Elahi M, et al. Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005–2008. Epidemiol Infect. 2012;140(9):1678–1684.
   PubMed Web of Science ®Google Scholar
• Alam M, Islam MT, Rashed SM, et al. Vibrio cholerae classical biotype strains reveal distinct signatures in Mexico. J Clin Microbiol. 2012;50(7):2212–2216.
   PubMed Web of Science ®Google Scholar
• Amita M, Chowdhury SR, Thungapathra M, et al. Class I integrons and SXT elements in El Tor strains isolated before and after 1992 Vibrio cholerae O139 outbreak, Calcutta, India. Emerg Infect Dis. 2003;9(4):500.
   PubMed Web of Science ®Google Scholar
• Anand V, Arora S, Patwari A, et al. Multidrug resistance in Vibrio cholerae. Indian Pediatr. 1996;33(9):774–778.
   PubMedGoogle Scholar
• Araj GF, Uwaydah MM, Alami SY. Antimicrobial susceptibility patterns of bacterial isolates at the American University Medical Center in Lebanon. Diagn Microbiol Infect Dis. 1994;20(3):151–158.
   PubMed Web of Science ®Google Scholar
• Baddam R, Sarker N, Ahmed D, et al. Genome dynamics of Vibrio cholerae isolates linked to seasonal outbreaks of cholera in Dhaka, Bangladesh. MBio. 2020;11(1). DOI:10.1128/mBio.03339-19.
   PubMed Web of Science ®Google Scholar
• Bag P, Maiti S, Sharma C, et al. Rapid spread of the new clone of Vibrio cholerae O1 biotype El Tor in cholera endemic areas in India. Epidemiol Infect. 1998;121(2):245–251.
   PubMed Web of Science ®Google Scholar
• Bakhshi B, Eftekhari N, Pourshafie MR. Genetic elements associated with antimicrobial resistance among intestinal bacteria. Jundishapur J Microbiol. 2014;7(5). DOI:10.5812/jjm.9924
   PubMed Web of Science ®Google Scholar
• Bakhshi B, Mahmoudi-Aznaveh A, Salimi-Khorashad A. Clonal dissemination of a single Vibrio cholerae O1 biotype El Tor strain in Sistan–Baluchestan province of Iran during 2013. Curr Microbiol. 2015;71(2):163–169.
   PubMed Web of Science ®Google Scholar
• Bakhshi B, Pourshafie MR. Assessing clonality of Vibrio cholerae strains isolated during four consecutive years (2004–2007) in Iran. Scand J Infect Dis. 2009;41(4):256–262.
   PubMed Web of Science ®Google Scholar
• Bakhshi B, Pourshafiei M, Navab AF, et al. Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholera. 2008;
   Google Scholar
• Balaji K, Okonjo PA, Thenmozhi R, et al. Virulence and multidrug resistance patterns of Vibrio cholerae O1 isolates from diarrheal outbreaks of South India during 2006–2009. Microbial Drug Resist. 2013;19(3):198–203.
   PubMed Web of Science ®Google Scholar
• Ballal M, Shivananda P. Rotavirus and enteric pathogens in infantile diarrhoea in Manipal, South India. Indian J Pediatr. 2002;69(5):393–396.
   PubMedGoogle Scholar
• Bani S, Mastromarino PN, Ceccarelli D, et al. Molecular characterization of ICE Vch Vie0 and its disappearance in Vibrio cholerae O1 strains isolated in 2003 in Vietnam. FEMS Microbiol Lett. 2007;266(1):42–48.
   PubMed Web of Science ®Google Scholar
• Barati H, Moradi G, Rasouli MA, et al. Epidemiologic and drug resistance pattern of Vibrio cholerae O1 biotype El Tor, serotype Ogawa, in the 2011 cholera outbreak, in Alborz Province, Iran. Jundishapur J Microbiol. 2015;8(11). DOI:10.5812/jjm.23477.
   PubMed Web of Science ®Google Scholar
• Basu A, Garg P, Datta S, et al. Vibrio cholerae O139 in Calcutta, 1992-1998: incidence, antibiograms, and genotypes. Emerg Infect Dis. 2000;6(2):139.
   PubMed Web of Science ®Google Scholar
• Bhat T, Yousuf I, Wani MA, et al. ANTI MICROBIAL SENSITIVITY PATTERN OF CHOLERA EPIDEMIC IN KASHMIR VALLEY. JK-Practitioner. 2012;17(4):26–28.
   Google Scholar
• Bhattacharya D, Dey S, Roy S, et al. Multidrug-resistant Vibrio cholerae O1 was responsible for a cholera outbreak in 2013 in Bagalkot, North Karnataka. Jpn J Infect Dis. 2015;68(4):347–350.
   PubMed Web of Science ®Google Scholar
• Bhotra T, Das M, Pal B, et al. Genomic profile of antibiotic resistant, classical ctxB positive Vibrio cholerae O1 biotype El Tor isolated in 2003 and 2005 from Puri, India: a retrospective study. Indian J Med Microbiol. 2017;34(4):462–470.
   Web of Science ®Google Scholar
• Bhowmick TS, Das M, Roy N, et al. Phenotypic and molecular typing of Vibrio cholerae O1 and O139 isolates from India. J Infect. 2007;54(5):475–482.
   PubMed Web of Science ®Google Scholar
• Bier N, Schwartz K, Guerra B, et al. Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Front Microbiol. 2015;6:1179.
   PubMed Web of Science ®Google Scholar
• Borkakoty B, Biswas D, Devi U, et al. Emergence of classical ctxB genotype 1 and tetracycline resistant strains of Vibrio cholerae O1 El Tor in Assam, India. Trans R Soc Trop Med Hyg. 2012;106(6):382–386.
   PubMed Web of Science ®Google Scholar
• Campos L, Zahner V, Avelar K, et al. Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance. Epidemiol Infect. 2004;132(5):985–992.
   PubMed Web of Science ®Google Scholar
• Ceccarelli D, Alam M, Huq A, et al. Reduced susceptibility to extended-spectrum β-lactams in Vibrio cholerae isolated in Bangladesh. Front Public Health. 2016;4:231.
   PubMed Web of Science ®Google Scholar
• Ceccarelli D, Spagnoletti M, Bacciu D, et al. New V. cholerae atypical El Tor variant emerged during the 2006 epidemic outbreak in Angola. BMC Microbiol. 2011;11(1):1–8.
   PubMedGoogle Scholar
• Ceccarelli D, Spagnoletti M, Bacciu D, et al. ICEVchInd5 is prevalent in epidemic Vibrio cholerae O1 El Tor strains isolated in India. Int J Med Microbiol. 2011;301(4):318–324.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Deokule J, Garg P, et al. Concomitant infection of enterotoxigenicEscherichia coli in an outbreak of cholera caused byVibrio cholerae O1 and O139 in Ahmedabad, India. J Clin Microbiol. 2001;39(9):3241–3246.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar M, Krishna B, Patil AB. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health. 2008;39(6):1092–1097.
   PubMedGoogle Scholar
• Chatterjee S, Ghosh K, Raychoudhuri A, et al. Phenotypic and genotypic traits and epidemiological implication of Vibrio cholerae O1 and O139 strains in India during 2003. J Med Microbiol. 2007;56(6):824–832.
   PubMed Web of Science ®Google Scholar
• Chhotray G, Pal B, Khuntia H, et al. Incidence and molecular analysis of Vibrio cholerae associated with cholera outbreak subsequent to the super cyclone in Orissa, India. Epidemiol Infect. 2002;128(2):131–138.
   PubMed Web of Science ®Google Scholar
• Chiyangi H, Muma JB, and Malama S, et al. Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0-59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross sectional study. BMC Infect Dis. 2017;17(1):117.
   PubMedGoogle Scholar
• Chomvarin C, Johura F-T, Mannan SB, et al. Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003–2011. J Med Microbiol. 2013;62(Pt 4):599.
   PubMedGoogle Scholar
• Chomvarin C, Jumroenjit W, Wongboot W, et al. Molecular analysis and antimicrobial resistance of Vibrio cholerae O1 in northeastern Thailand. Southeast Asian J Trop Med Public Health. 2012;43(6): 1437
   PubMed Web of Science ®Google Scholar
• Chowdhury G, Bhadra RK, Bag S, et al. Rugose atypical Vibrio cholerae O1 El Tor responsible for 2009 cholera outbreak in India. J Med Microbiol. 2016;65(10):1130–1136.
   PubMedGoogle Scholar
• Colombo M, Francisco M, Ferreira B, et al. The early stage of the recurrent cholera epidemic in Luanda, Angola. Eur J Epidemiol. 1993;9(5):563–565.
   PubMed Web of Science ®Google Scholar
• Dalsgaard A, Forslund A, Petersen A, et al. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic Vibrio cholerae O1 strains isolated in Guinea-Bissau. J Clin Microbiol. 2000;38(10):3774–3779.
   PubMed Web of Science ®Google Scholar
• Dalsgaard A, Forslund A, Tam N, et al. Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in Vibrio cholerae O1 strains isolated from 1979 to 1996. J Clin Microbiol. 1999;37(3):734–741.
   PubMed Web of Science ®Google Scholar
• Dalsgaard A, Mortensen HF, Mølbak K, et al. Molecular characterization of Vibrio cholerae O1 strains isolated during cholera outbreaks in Guinea-Bissau. J Clin Microbiol. 1996;34(5):1189–1192.
   PubMed Web of Science ®Google Scholar
• Dalsgaard A, Serichantalergs O, Forslund A, et al. Phenotypic and molecular characterization of Vibrio cholerae O1 isolated in Samutsakorn, Thailand before, during and after the emergence of V. cholerae O139. Epidemiol Infect. 1998;121(2):259–268.
   PubMed Web of Science ®Google Scholar
• Das MM, Bhotra T, Zala D, et al. Phenotypic and genetic characteristics of Vibrio cholerae O1 carrying Haitian ctxB and attributes of classical and El Tor biotypes isolated from Silvassa, India. J Med Microbiol. 2016;65(8):720–728.
   PubMedGoogle Scholar
• Das S, Choudhry S, Saha R, et al. Emergence of multiple drug resistance Vibrio cholerae O1 in East Delhi. J Infect Dev Ctries. 2011;5(4):294–298.
   PubMed Web of Science ®Google Scholar
• Das S, Goyal R, Ramachandran V, et al. Fluoroquinolone resistance in Vibrio cholerae O1: emergence of El Tor Inaba. Ann Trop Paediatrics. 2005;25(3):211–212.
   PubMed Web of Science ®Google Scholar
• Das S, and Gupta S. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000. J Health Popul Nutr. 2005;23(1) ;44–51.
   PubMed Web of Science ®Google Scholar
• Das S, Saha R, Kaur IR. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi. Indian J Med Res. 2008;127(5):478.
   PubMed Web of Science ®Google Scholar
• Das SK, Ahmed S, Ferdous F, et al. Etiological diversity of diarrhoeal disease in Bangladesh. J Infect Dev Ctries. 2013;7(12):900–909.
   PubMed Web of Science ®Google Scholar
• Dengo-Baloi LC, Semá-Baltazar CA, Manhique LV, et al. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PloS one. 2017;12(8):e0181496.
   PubMed Web of Science ®Google Scholar
• Dey S, Parande MV, Parande AM, et al. Twin outbreak of cholera in rural North Karnataka, India. Indian J Med Res. 2014;140(3):420.
   PubMedGoogle Scholar
• Dixit SM, Johura F-T, Manandhar S, et al. Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio cholerae O1. BMC Infect Dis. 2014;14(1):1–11.
   PubMedGoogle Scholar
• Echeverria P, Pitarangsi C, Eampokalap B, et al. A longitudinal study of the prevalence of bacterial enteric pathogens among adults with diarrhea in Bangkok, Thailand. Diagn Microbiol Infect Dis. 1983;1(3):193–204.
   PubMed Web of Science ®Google Scholar
• Ehara M, Nguyen B, Nguyen D, et al. Drug susceptibility and its genetic basis in epidemic Vibrio cholerae O1 in Vietnam. Epidemiol Infect. 2004;132(4):595–600.
   PubMed Web of Science ®Google Scholar
• Eibach D, Herrera-Leon S, Gil H, et al. Molecular epidemiology and antibiotic susceptibility of Vibrio cholerae associated with a large cholera outbreak in Ghana in. PLoS Negl Trop Dis. 2014;10(5):e0004751. 2016.
   Web of Science ®Google Scholar
• Faruque SM, Chowdhury N, Kamruzzaman M, et al. Reemergence of epidemic Vibrio cholerae O139, Bangladesh. Emerg Infect Dis. 2003;9(9):1116.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Saha MN, Bag PK, et al. Genomic diversity among Vibrio cholerae O139 strains isolated in Bangladesh and India between 1992 and 1998. FEMS Microbiol Lett. 2000;184(2):279–284.
   PubMed Web of Science ®Google Scholar
• Faruque SM, Siddique A, Saha MN, et al. Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh. J Clin Microbiol. 1999;37(5):1313–1318.
   PubMed Web of Science ®Google Scholar
• Fazil MT, Bhanumathi R, Pandey H, et al. Characterization of Vibrio cholerae O139 belonging to multiple ribotypes and isolated from diarrhoeal patients in Kerala, southern India. Infect Genet Evol. 2011;11(2):454–459.
   PubMed Web of Science ®Google Scholar
• Feglo PK, Sewurah M. Characterization of highly virulent multidrug resistant Vibrio cholerae isolated from a large cholera outbreak in Ghana. BMC Res Notes. 2018;11(1):1–6.
   PubMedGoogle Scholar
• Folgosa E, Mastrandrea S, Cappuccinelli P, et al. Molecular identification of pathogenicity genes and ERIC types in Vibrio cholerae O1 epidemic strains from Mozambique. Epidemiol Infect. 2000;127(1):17–25.
   Web of Science ®Google Scholar
• Garg P, Chakraborty S, Basu I, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992–7 in Calcutta, India. Epidemiol Infect. 2000;124(3):393–399.
   PubMed Web of Science ®Google Scholar
• Glass RI, Huq I, Alim A, et al. Emergence of multiple antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis. 1980;142(6):939–942.
   PubMed Web of Science ®Google Scholar
• Goel A, Jain M, Kumar P, et al. Molecular characterization of Vibrio cholerae outbreak strains with altered El Tor biotype from southern India. World J Microbiol Biotechnol. 2010;26(2):281–287.
   PubMed Web of Science ®Google Scholar
• Goel A, Jiang S. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infect Genet Evol. 2010;10(6):814–818.
   Web of Science ®Google Scholar
• Gu W, Yin J, Yang J, et al. Characterization of Vibrio cholerae from 1986 to 2012 in Yunnan province, southwest China bordering Myanmar. Infect Genet Evol. 2014;21:1–7.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Pant ND, Bhandari R, et al. Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrob Resist Infect Control. 2016;5(1):1–5.
   PubMedGoogle Scholar
• Ibarra J, Alvarado D. Antimicrobial resistance of clinical and environmental strains of Vibrio cholerae isolated in Lima-Peru during epidemics of 1991 and 1998. Braz J Infect Dis. 2007;11(1):100–105.
   PubMed Web of Science ®Google Scholar
• Iramiot JS, Rwego IB, Kansiime C, et al. Epidemiology and antibiotic susceptibility of Vibrio cholerae associated with the 2017 outbreak in Kasese district, Uganda. BMC Public Health. 2019;19(1):1–9.
   PubMed Web of Science ®Google Scholar
• Islam MS, Mahmud ZH, Ansaruzzaman M, et al. Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe. J Clin Microbiol. 2011;49(6):2325–2327.
   PubMed Web of Science ®Google Scholar
• Ismail H, Smith AM, Tau NP, et al. Cholera outbreak in South Africa, 2008–2009: laboratory analysis of Vibrio cholerae O1 strains. J Infect Dis. 2013;208(suppl_1):S39–S45.
   PubMedGoogle Scholar
• Jabeen K, Zafar A, Hasan R. Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan. EMHJ-East Mediterranean Health J. 2008;14(3):564–570.
   PubMedGoogle Scholar
• Jain M, Goel A, Bhattacharya P, et al. Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India. Acta Trop. 2011;117(2):152–156.
   PubMed Web of Science ®Google Scholar
• Jain M, Kumar P, Goel A. Emergence of tetracycline resistant vibrio cholerae O1 biotype El Tor serotype Ogawa with classical ctxB gene from a cholera outbreak in Odisha, Eastern India. J Pathog. 2016;2016:1–6.
   Google Scholar
• Jaiswal A, Sarkar S, Das P, et al. Trends in the genomic epidemiology of Vibrio cholerae O1 isolated worldwide since 1961. Int J Antimicrob Agents. 2015;46(4):460–464.
   PubMed Web of Science ®Google Scholar
• Jena PP, Gur R, Sharma A, et al. Antibiotic susceptibility profile of ‘Vibrio Cholerae O1 Biotype El Tor Serotype Ogawa’outbreak in North Delhi, India. J Pediatr Infect Dis. 2018;13(4):277–282.
   Web of Science ®Google Scholar
• Kacou-N’douba A, Okpo LS, Elogne-Kouamé C, et al. Antimicrobial resistance of Vibrio cholerae O1 isolated during a cholera epidemic in 2011 in dry season in Cote d’Ivoire. J Infect Dev Ctries. 2012;6(7):595–597.
   PubMed Web of Science ®Google Scholar
• Kaistha N, Mehta M, Gautam V, et al. Outbreak of cholera in & around Chandigarh during two successive years (2002, 2003). Indian J Med Res. 2005;122(5):404.
   PubMed Web of Science ®Google Scholar
• Kansakar P, Baral P, Malla S, et al. Antimicrobial susceptibilities of enteric bacterial pathogens isolated in Kathmandu, Nepal, during 2002-2004. J Infect Dev Ctries. 2011;5(3):163–168.
   PubMed Web of Science ®Google Scholar
• Kar SK, Pal BB, Khuntia HK, et al. Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India. Inter J Infect Dis. 2015;33:45–49.
   PubMed Web of Science ®Google Scholar
• Karki R, Bhatta DR, Malla S, et al. Cholera incidence among patients with diarrhea visiting National Public Health Laboratory, Nepal. Jpn J Infect Dis. 2010;63(3):185–187.
   PubMed Web of Science ®Google Scholar
• Keramat F, Hashemi S, Mamani M, et al. Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran. EMHJ-East Mediterranean Health J. 2008;14(4):768–775.
   PubMedGoogle Scholar
• Khuntia HK, Samal SK, Sahoo RK, et al. Escalating emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 and O139 among hospitalized patients with cholera in Orissa, India. J Pure Appl Microbiol. 2009;3(2):811–814.
   Web of Science ®Google Scholar
• Kiiru J, Mutreja A, Mohamed AA, et al. A study on the geophylogeny of clinical and environmental Vibrio cholerae in Kenya. PLoS One. 2013;8(9):e74829.
   PubMed Web of Science ®Google Scholar
• Kingston J, Thavachelvam K, Tuteja U, et al. Antimicrobial susceptibility and molecular characterization of Vibrio cholerae from cholera outbreaks in Chennai. Indian J Microbiol. 2009;49(1):84–88.
   PubMed Web of Science ®Google Scholar
• Koley H, Ray N, Chowdhury G, et al. Outbreak of cholera caused by Vibrio cholerae O1 El Tor variant strain in Bihar, India. Jpn J Infect Dis. 2014;67(3):221–226.
   PubMed Web of Science ®Google Scholar
• Kondo S, Kongmuang U, Kalnauwakul S, et al. Molecular epidemiologic analysis of Vibrio cholerae O1 isolated during the 1997–8 cholera epidemic in southern Thailand. Epidemiol Infect. 2001;127(1):7–16.
   PubMed Web of Science ®Google Scholar
• Koo D, Aragon A, Moscoso V, et al. Epidemic cholera in Guatemala, 1993: transmission of a newly introduced epidemic strain by street vendors. Epidemiol Infect. 1996;116(2):121–126.
   PubMed Web of Science ®Google Scholar
• Krishna B, Patil AB, Chandrasekhar M. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India. Trans R Soc Trop Med Hyg. 2006;100(3):224–226.
   PubMed Web of Science ®Google Scholar
• Kumar P, Mishra D, Deshmukh D, et al. Haitian variant ctxB producing V ibrio cholerae O1 with reduced susceptibility to ciprofloxacin is persistent in Y avatmal, M aharashtra, I ndia, after causing a cholera outbreak. Clin Microbiol Infect. 2014;20(5):O292–O293.
   PubMed Web of Science ®Google Scholar
• Kutar BM, Rajpara N, Upadhyay H, et al. Clinical isolates of Vibrio cholerae O1 El Tor Ogawa of 2009 from Kolkata, India: preponderance of SXT element and presence of Haitian ctxB variant. PLoS One. 2013;8(2):e56477.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang W, Duan G, et al. Study of drug resistance and molecular typing of 59 cholerae01 clinical isolates from 1984 to 2002 in Chongqing, China. Int J Clin Exp Med. 2013;6(10):930.
   PubMed Web of Science ®Google Scholar
• Maharjan S, Rayamajhee B, Shreshtha A, et al. Serotyping and antibiotic susceptibility patterns of Vibrio and Shigella isolates from diarrheal patients visiting a Tropical and Infectious Diseases Hospital in central Nepal. BMC Res Notes. 2017;10(1):1–7.
   PubMed Web of Science ®Google Scholar
• Mandal S, DebMandal M, Pal NK. Plasmid mediated antibiotic resistance of Vibrio cholerae O1 biotype El Tor serotype Ogawa associated with an outbreak in Kolkata, India. Asian Pac J Trop Med. 2010;3(8):637–641.
   Web of Science ®Google Scholar
• Mandal S, Pal NK, Chowdhury IH, et al. Antibacterial activity of ciprofloxacin and trimethoprim, alone and in combination, against Vibrio cholerae O 1 Biotype El Tor serotype Ogawa isolates. Pol J Microbiol. 2009;58(1):57–60.
   PubMed Web of Science ®Google Scholar
• Mandomando I, Espasa M, Vallès X, et al. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhica District Hospital, southern Mozambique. J Antimicrob Chemother. 2007;60(3):662–664.
   PubMed Web of Science ®Google Scholar
• Marashi SMA, Esfahani BN, Tavakoli A, et al. Simultaneous detection of integrase and antibiotic resistance genes within SXT Constin in Vibrio cholerae O1 El Tor strains isolated from Iran using multiplex-PCR. Iran J Basic Med Sci. 2012;15(3):885.
   PubMed Web of Science ®Google Scholar
• Mohapatra SS, Ramachandran D, Mantri CK, et al. Characterization of the genetic background of Vibrio cholerae O1 biotype El Tor serotype Inaba strains isolated in Trivandrum, southern India. J Med Microbiol. 2007;56(2):260–265.
   PubMed Web of Science ®Google Scholar
• Moyo SJ, Gro N, Matee MI, et al. Age specific aetiological agents of diarrhoea in hospitalized children aged less than five years in Dar es Salaam, Tanzania. BMC Pediatr. 2011;11(1):1–6.
   PubMedGoogle Scholar
• Mukhopadhyay AK, Deb AK, and Chowdhury G, et al. Post-monsoon waterlogging-associated upsurge of cholera cases in and around Kolkata metropolis, 2015. Epidemiol Infect. 2019;147:e167.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay A, Garg S, Nair GB, et al. Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup. Epidemiol Infect. 1995;115(3):427–434.
   PubMed Web of Science ®Google Scholar
• Mwansa J, Mwaba J, Lukwesa C, et al. Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerge during cholera outbreaks in Zambia. Epidemiol Infect. 2007;135(5):847–853.
   PubMed Web of Science ®Google Scholar
• Ngandjio A, Tejiokem M, Wouafo M, et al. Antimicrobial resistance and molecular characterization of Vibrio cholerae O1 during the 2004 and 2005 outbreak of cholera in Cameroon. Foodborne Pathog Dis. 2009;6(1):49–56.
   PubMed Web of Science ®Google Scholar
• Nishibori T, de Vries GC, Rahardjo D, et al. Phenotypic and genotypic characterization of Vibrio cholerae clinically isolated in Surabaya, Indonesia. Jpn J Infect Dis. 2011;64(1):7–12.
   PubMed Web of Science ®Google Scholar
• Okuda J, Ramamurthy T, Yamasaki S. Antibacterial activity of ciprofloxacin against clinical strains of Vibrio cholerae O139 recently isolated from India. Yakugaku Zasshi. 2007;127(5):903–904.
   PubMed Web of Science ®Google Scholar
• Okuda J, Ramamurthy T, Yamasaki S. The potent antibacterial activity of sitafloxacin against fluoroquinolone‐resistant clinical isolates of Vibrio cholerae O1. Microbiol Immunol. 2007;51(4):467–469.
   PubMed Web of Science ®Google Scholar
• Oyofo BA, Lesmana M, Subekti D, et al. Surveillance of bacterial pathogens of diarrhea disease in Indonesia. Diagn Microbiol Infect Dis. 2002;44(3):227–234.
   PubMed Web of Science ®Google Scholar
• Oyofo BA, Subekti D, Tjaniadi P, et al. Enteropathogens associated with acute diarrhea in community and hospital patients in Jakarta, Indonesia. FEMS Immunol Med Microbiol. 2002;34(2):139–146.
   PubMedGoogle Scholar
• Pal BB, Khuntia HK, Samal SK, et al. Emergence of Vibrio cholerae O1 biotype E1 Tor serotype Inaba causing outbreaks of cholera in Orissa, India. Jpn J Infect Dis. 2006;59(4):266.
   PubMed Web of Science ®Google Scholar
• Pal BB, Nayak SR, Khuntia HK. Epidemiology and antibiogram profile of Vibrio cholerae isolates between 2004-2013 from Odisha, India. Jpn J Infect Dis. 2017;193:JJID.
   Google Scholar
• Pan J-C, Ye R, Wang H-Q, et al. Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids. Antimicrob Agents Chemother. 2008;52(11):3829–3836.
   PubMed Web of Science ®Google Scholar
• Parveen S, Farrah SR, Gonzalez-Bonilla C, et al. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico. Can J Microbiol. 2003 Jan;49(1):65–70.
   PubMed Web of Science ®Google Scholar
• Patrick G, Nishibuchi M, Tunung R, et al. Molecular characterization of clinical isolate of Vibrio cholerae isolated from outbreaks cases in Malaysia. Int Food Res J. 2012;19(3):1267.
   Google Scholar
• Radu S, Vincent M, Apun K, et al. Molecular characterization of Vibrio cholerae O1 outbreak strains in Miri, Sarawak (Malaysia). Acta Trop. 2002;83(2):169–176.
   PubMed Web of Science ®Google Scholar
• Rahbar M, Zahraei M, Omidvarnia A, et al. Survey of epidemiology and bacteriology features of cholera in Iran. Asian Pac J Trop Med. 2010;3(1):45–47.
   Web of Science ®Google Scholar
• Ranjbar R, Sadeghy J, Moghadam MS, et al. Multi-locus variable number tandem repeat analysis of Vibrio cholerae isolates from 2012 to 2013 cholera outbreaks in Iran. Microb Pathog. 2016;97:84–88.
   PubMed Web of Science ®Google Scholar
• Ranjit K, Nurahan M. Tetracycline resistant cholera in Kelantan. Med J Malays. 2000;55(1):143–145.
   PubMedGoogle Scholar
• Rashed SM, Mannan SB, Johura F-T, et al. Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006–2011. J Med Microbiol. 2012;61(Pt 12):1736.
   PubMed Web of Science ®Google Scholar
• Rezaie N, Bakhshi B, Najar-Peerayeh S. Distribution of resistance genetic determinants among Vibrio cholerae isolates of 2012 and 2013 outbreaks in IR Iran. Microb Pathog. 2017;104:12–16.
   PubMed Web of Science ®Google Scholar
• Rijal N, Acharya J, Adhikari S, et al. Changing epidemiology and antimicrobial resistance in Vibrio cholerae: AMR surveillance findings (2006–2016) from Nepal. BMC Infect Dis. 2019;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Roy S, Parande M, Mantur B, et al. Multidrug-resistant Vibrio cholerae O1 in Belgaum, south India. J Med Microbiol. 2012;61(11):1574–1579.
   PubMed Web of Science ®Google Scholar
• Saidi SM, Chowdhury N, Awasthi SP, et al. Prevalence of Vibrio cholerae O1 El Tor variant in a cholera-endemic zone of Kenya. J Med Microbiol. 2014;63(3):415–420.
   PubMedGoogle Scholar
• Sambe-Ba B, Diallo MH, Seck A, et al. Identification of atypical El TorV. cholerae O1 Ogawa hosting SXT element in Senegal, Africa. Front Microbiol. 2017;8:748.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Morita D, Ghosh A, et al. Altered integrative and conjugative elements (ICEs) in recent Vibrio cholerae O1 isolated from cholera cases, Kolkata, India. Front Microbiol. 2019;10:2072.
   PubMed Web of Science ®Google Scholar
• Scrascia M, Pugliese N, Maimone F, et al. Cholera in Ethiopia in the 1990s: epidemiologic patterns, clonal analysis, and antimicrobial resistance. Int J Med Microbiol. 2009;299(5):367–372.
   PubMed Web of Science ®Google Scholar
• Scrascia M, Pugliese N, Maimone F, et al. Clonal relationship among Vibrio cholerae O1 El Tor strains isolated in Somalia. Int J Med Microbiol. 2009;299(3):203–207.
   PubMed Web of Science ®Google Scholar
• Sedaghat M, Rahimi F, Talebi M, et al. Serotyping, antibiotic susceptibility pattern and detection of hlyA gene among Cholera patients in Iran. Jundishapur J Microbiol. 2012;6(1):20–23.
   Web of Science ®Google Scholar
• Shakya G, Kim DW, Clemens JD, et al. Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal. World J Microbiol Biotechnol. 2012;28(8):2671–2678.
   PubMed Web of Science ®Google Scholar
• Shapiro RL, Kumar L, Phillips-Howard P, et al. Antimicrobial-resistant bacterial diarrhea in rural western Kenya. J Infect Dis. 2001;183(11):1701–1704.
   PubMed Web of Science ®Google Scholar
• Sharma N, Mandal P, Dhillon R, et al. Changing profile of Vibrio cholerae 01, 0139 in Delhi & its periphery (2003-2005). Indian J Med Res. 2007;125(5):633.
   PubMed Web of Science ®Google Scholar
• Talkington D, Bopp C, Tarr C, et al. Characterization of toxigenic Vibrio cholerae from Haiti, 2010–2011. Emerg Infect Dis. 2011;17(11):2122.
   PubMed Web of Science ®Google Scholar
• Torane V, Kuyare S, Nataraj G, et al. Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004–2013: a retrospective cross-sectional study. BMJ open. 2016;6(11):e012638.
   PubMed Web of Science ®Google Scholar
• Tran HD, Alam M, Trung NV, et al. Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010. J Med Microbiol. 2012;61(Pt 3):431.
   PubMed Web of Science ®Google Scholar
• Urassa W, Mhando Y, Mhalu F, et al. Antimicrobial susceptibility pattern of Vibrio cholerae 01 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East Afr Med J. 2000;77(7):350–353.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi N, Rao R, Badrinath S. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry. Epidemiol Infect. 1997;119(1):25–28.
   PubMed Web of Science ®Google Scholar
• Vinothkumar K, Bhalara SR, Shah A, et al. Involvement of topoisomerase mutations and qnr and aac (6′) Ib-cr genes in conferring quinolone resistance to clinical isolates of Vibrio and Shigella spp. from Kolkata, India (1998–2009). J Glob Antimicrob Resist. 2018;13:85–90.
   PubMed Web of Science ®Google Scholar
• Wabale VR, Joshi AA, Bharadwaj RS, et al. Acute gastroenteritis (age) due to vibrio cholerae El-Tor Ogawa In Mumbai–A 5 year study.
   Google Scholar
• Waldor MK, Tschäpe H, Mekalanos JJ. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol. 1996;178(14):4157–4165.
   PubMed Web of Science ®Google Scholar
• Zahid MSH, Awasthi SP, and Hinenoya A, et al. Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro. J Vet Med Sci. 2015;77(5):535–540.
   PubMed Web of Science ®Google Scholar
• Yousefi A, Vaez H, Sahebkar A, et al. A systematic review and meta-analysis on the epidemiology of antibiotic resistance of Vibrio cholerae in Iran. Annali di Igiene, Medicina Preventiva e di Comunità. 2019;31(3): 279–290
   PubMed Web of Science ®Google Scholar
• Islam MS, Midzi SM, Charimari L, et al. Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe. Jama. 2009;302(21):2321–2322.
   PubMed Web of Science ®Google Scholar
• Danso EK, Asare P, Otchere ID, et al. A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana. Plos one. 2020;15(7):e0236016.
   PubMed Web of Science ®Google Scholar
• Masoumi-Asl H, Gouya MM, Rahbar M, et al. The epidemiology and antimicrobial resistance of cholera cases in Iran during 2013. Iran J Microbiol. 2016;8(4):232.
   PubMedGoogle Scholar
• Uppal B, Mehra B, Panda PS, et al. Changing epidemiology and antimicrobial resistance pattern of Vibrio cholerae isolates at a tertiary care health laboratory in North India (2011–2015). Water Supply. 2017;4:6.
   Google Scholar
• Shah R, Parveen G, Shoukat M, et al. Isolation, identification, characterization and antibiotic susceptibility of Vibrio cholerae during 1998-99. Int J Biosci. 2017;11(3):135–147.
   Google Scholar
• Chatterjee P, Kanungo S, Bhattacharya SK, et al. Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: an assessment of existing data and a scoping review of the literature. Vaccine. 2020;38:A93–A104.
   PubMed Web of Science ®Google Scholar
• Ahmadi MH. Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2021;10(1):1–12.
   PubMed Web of Science ®Google Scholar
• Loo KY, Letchumanan V, Law JWF, et al. Incidence of antibiotic resistance in Vibrio spp. Revi Aquacult. 2020;12(4):2590–2608.
   Web of Science ®Google Scholar
• Narendrakumar L, Gupta SS, Johnson JB, et al. Molecular adaptations and antibiotic resistance in Vibrio cholerae: a communal challenge. Microbial Drug Resist. 2019;25(7):1012–1022.
   PubMed Web of Science ®Google Scholar
• Kitaoka M, Miyata ST, Unterweger D, et al. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol. 2011;60(4):397–407.
   PubMed Web of Science ®Google Scholar
• Singh AK, Haldar R, Mandal D, et al. Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance. Antimicrob Agents Chemother. 2006;50(11):3717–3723.
   PubMed Web of Science ®Google Scholar
• Morita D, Takahashi E, Morita M, et al. Genomic characterization of antibiotic resistance‐encoding genes in clinical isolates of Vibrio cholerae non‐O1/non‐O139 strains from Kolkata, India: generation of novel types of genomic islands containing plural antibiotic resistance genes. Microbiol Immunol. 2020;64(6):435–444.
   PubMed Web of Science ®Google Scholar